Biosecurity and supply-chain risks arising from COVID-19
First written in FY2020. 10 of 12 entries say "Restated". Latest entry: FY2026.
No other company in this theme has enough history to compare yet.
- FY2026DroppedAnnual reportThe current year's business and other risks do not explicitly mention biosecurity or supply-chain risks arising from COVID-19.
- FY2024-Q2RestatedAnnual report
「During the cumulative second quarter of the current consolidated fiscal year, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The company states that there have been no new developments or material changes in the risks described in the previous fiscal year, including COVID-19. - FY2024-Q1RestatedAnnual report
「During the cumulative first quarter under review, there were no new business or other risks, nor any material changes to the business or other risks described in the annual securities report for the previous fiscal year.」
The company states that there have been no new developments or material changes in the risks described in the previous fiscal year, including COVID-19. - FY2023-Q3RestatedAnnual report
「During the cumulative third quarter of the current consolidated fiscal year, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The company states that there have been no new developments or material changes in the risks described in the previous fiscal year, including COVID-19. - FY2023-Q2RestatedAnnual report
「During the cumulative second quarter of the current consolidated fiscal year, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The company states that there have been no new developments or material changes in the risks described in the previous fiscal year, including COVID-19. - FY2023-Q1RestatedAnnual report
「During the cumulative first quarter under review, there were no new business or other risks, nor any material changes to the business or other risks described in the annual securities report for the previous fiscal year.」
The company states that there have been no new developments or material changes in the risks described in the previous fiscal year, including COVID-19. - FY2022-Q3RestatedAnnual report
「During the cumulative third quarter of the current consolidated fiscal year, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The company states that there have been no new developments or material changes in the risks described in the previous fiscal year, including COVID-19. - FY2021RestatedAnnual report
「However, if COVID-19 infections spread substantially in Yamaguchi Prefecture and the Kyushu region, where our group is based, and infections among employees within our group are confirmed, we may be unable to continue normal production activities at our plants and farms, potentially resulting in a substantial decline in sales.」
The risks of production stoppages at plants and farms due to internal infections and supply-chain disruption caused by prolonged infections continue to be cited. - FY2021-Q3RestatedAnnual report
「During the cumulative third quarter of the current consolidated fiscal year, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The company states that there have been no new developments or material changes in the risks described in the previous fiscal year, including COVID-19. - FY2021-Q2RestatedAnnual report
「During the cumulative second quarter of the current consolidated fiscal year, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The company states that there have been no new developments or material changes in the risks described in the previous fiscal year, including COVID-19. - FY2021-Q1RestatedAnnual report
「During the cumulative first quarter under review, there were no new business or other risks, nor any material changes to the business or other risks described in the annual securities report for the previous fiscal year.」
The company states that there have been no new developments or material changes in the risks described in the previous fiscal year, including COVID-19. - FY2020First statedAnnual report
「However, if COVID-19 infections spread substantially in Yamaguchi Prefecture and the Kyushu region, where our group is based, and infections among employees within our group are confirmed, we may be unable to continue normal production activities at our plants and farms, potentially resulting in a substantial decline in sales. If the spread of infections in Japan and overseas becomes increasingly severe and prolonged, the disruption of supply chains may also prevent us from conducting normal production and sales activities.」
The company disclosed for the first time, as major risks, the risk of production stoppages at plants and farms due to internal infections and the risk of supply-chain disruption caused by a prolonged spread of infections in Japan and overseas.